Search results
Showing 31 to 45 of 77 results for menopause
Evidence-based recommendations on palbociclib (Ibrance) with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.
This guideline covers diagnosing and managing endometriosis. It aims to raise awareness of the symptoms of endometriosis, and to provide clear advice on what action to take when women and people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.
symptoms. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued
This quality standard covers the recognition and initial management of ovarian cancer. It describes high-quality care in priority areas for improvement.
hormonal changes (which should includeeffects seen during puberty and menopause) and the severity and site of disease details of the...
Laparoscopic removal of uterine fibroids with power morcellation (IPG703)
Evidence-based recommendations on laparoscopic removal of uterine fibroids with power morcellation in adults. This involves cutting the fibroids into small pieces to remove them.
View recommendations for IPG703Show all sections
treatment. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued
Although breast density decreases with age, and particularly after the menopause, there is no sudden change at any particular age. For...
indicated. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued
Evidence-based recommendations on liposuction for chronic lipoedema in adults. This involves using suction to remove abnormal fat.
View recommendations for IPG721Show all sections
Evidence-based recommendations on pembrolizumab (Keytruda) with lenvatinib (Lenvima) for treating advanced or recurrent endometrial cancer in adults.
Find out more about quality standards advisory committee 2 members at NICE
More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE.
This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman’s quality of life and to offer the right treatments, taking into account the woman’s priorities and preferences.
Early and locally advanced breast cancer: diagnosis and management (NG101)
This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.